Catalyst PharmaceuticalsCPRX

那斯達克 · USD
31.27
-0.02
(-0.06%)
收盤 06/06 03:59 (UTC+8)
盤後 
31.29 
+0.02 
(+0.06%)
06/06 03:59 (UTC+8)

財務數據

損益表

loading
載入中...
icon
  • 1.11
  • 0.99
  • 1.23
  • 1.29
  • 1.42
  • 1.41
  • 1.47
  • 1.48
  • 1.53
  • 1.49
icon
  • 7.67
  • -10.91
  • 24.57
  • 4.88
  • 10.20
  • -0.28
  • 3.64
  • 1.25
  • 2.84
  • -2.11
  • icon
    營業收入(億)
  • icon
    季增長率(%)
單位:美元千元
年季
2026/Q1
2025/Q4
2025/Q3
2025/Q2
2025/Q1
2024/Q4
2024/Q3
2024/Q2
2024/Q1
2023/Q4
營業收入淨額
149,390
152,613
148,392
146,563
141,421
141,820
128,695
122,710
98,509
110,568
營業成本
14,47526,07422,65420,61417,91121,64319,27715,40512,52015,809
營業毛利
134,915
126,539
125,738
125,949
123,510
120,177
109,418
107,305
85,989
94,759
營業費用
61,68364,69359,47159,651---53,059-53,067
研發費用
2,6611,8072,6574,3583,8873,7983,2842,9852,5811,972
推銷及管理費用
49,31953,42147,47045,94946,91144,19245,88040,73046,93842,036
非經常性項目費用
----------
其他營業費用
9,7039,4659,3449,3449,3459,3449,3459,3449,3449,059
營業利益
73,232
61,846
66,267
66,298
63,367
62,843
50,909
54,246
27,126
41,692
其他收入及費用
10,99710,0554,7682,9957,91911,3386,2961,5421,9635,015
利息費用
----------
稅前純益
84,229
71,901
71,035
69,293
71,286
74,181
57,205
55,788
29,089
46,707
所得稅
20,49519,20318,25217,18514,54918,24513,32114,9945,81411,863
稅後純益
63,734
52,698
52,783
52,108
56,737
55,936
43,884
40,794
23,275
34,844
基本每股稅後盈餘(元)
0.520.430.430.430.470.470.370.350.20-
稀釋每股稅後盈餘(元)
0.500.410.410.410.450.440.350.330.190.31
基本平均股數(千股)
122254.00122907.00122600.00122163.00121472.00119892.00118931.00118180.00116806.00-
稀釋平均股數(千股)
126903.00127425.00127090.00127543.00126957.00126280.00125407.00124655.00123403.00-
還原基本每股稅後盈餘(元)
0.520.430.430.430.470.470.370.350.20-
還原稀釋每股稅後盈餘(元)
0.500.410.410.410.450.440.350.330.190.31
還原基本平均股數(千股)
122,254122,907122,600122,163121,472119,892118,931118,180116,806-
還原稀釋平均股數(千股)
126,903127,425127,090127,543126,957126,280125,407124,655123,403-
EBITDA(千元)
93,86781,32280,35578,67580,68683,60065,57365,35738,67256,024

大家都在看

HOT